Monsanto the world’s largest seed company, met this week with Syngenta shareholders in a bid to pressure the Swiss rival into negotiations after a $45 billion takeover offer was rejected.
Monsanto Chief Operating Officer Brett Begemann and Chief Technology Officer Robb Fraley met Monday and Tuesday in Europe to discuss the merits of the bid with Syngenta investors, many of whom also own Monsanto shares, said Scott Partridge, Monsanto’s vice president of strategy.
Some shareholders are frustrated the Basel, Switzerland-based company has refused to negotiate, he said.
Syngenta has snubbed Monsanto’s unsolicited offer of 449 Swiss francs ($480) a share, with 45 percent in cash, as too low and the execution risk too high. The bid represents a 43 percent premium to Syngenta’s share price at the close on April 30, just before Bloomberg News reported the proposal.
Monsanto said on Sunday it would pay a $2 billion breakup fee if regulators reject the deal, and it reiterated plans to sell overlapping seed and chemical units to overcome antitrust objections. Syngenta responded that its U.S. suitor has failed to convince it of the merits of a merger, calling the breakup fee “paltry” and saying the planned divestitures don’t resolve the regulatory issues.
Full content: The Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Google and South Carolina Clash Over State Records Demand
May 8, 2024 by
CPI
Telefonica Germany Teams Up with Amazon Web Services to Migrate 5G Customers
May 8, 2024 by
CPI
Federal Judge Grants $7.4 Million Settlement in Pork Price-Fixing Case
May 8, 2024 by
CPI
Wilson Sonsini Bolsters Antitrust and Competition Practice with Key Partner Returns
May 8, 2024 by
CPI
EU to Scrutinize Telecom Italia’s Network Sale to KKR
May 8, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI